权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Leveraging biobank-scale whole-genome sequencing for polygenic risk prediction

利用生物库规模的全基因组测序进行多基因风险预测

基本信息

批准号：
10716534
负责人：
Po-Ru Loh
金额：
$ 44.75万
依托单位：
BRIGHAM AND WOMEN'S HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-09-18 至 2027-07-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10716534
关键词：
Algorithms Alleles Base Pairing Blood Blood Cells Cardiovascular Diseases Chromosome abnormality Clonal Expansion Collaborations Complex Computer software Computing Methodologies DNA DNA Sequence Data Data Set Disease European ancestry Frequencies Future Gene Frequency Genes Genetic Genetic Diseases Genetic Models Genetic Polymorphism Genetic Risk Genetic Variation Genome Genomics Genotype Haplotypes Hematologic Neoplasms Heritability Individual Inherited Letters Link Mediating Memory Methodology Methods Modeling Mutation Mutation Detection Performance Point Mutation Population Publications Research Resolution Resources Risk SNP array Sampling Single Nucleotide Polymorphism Somatic Mutation Source Statistical Algorithm Statistical Methods Structure Therapeutic Training Variant age related analytical method biobank cardiovascular risk factor causal variant cohort cost disorder risk empowerment experience genetic risk factor genetic variant genome sequencing genome-wide genome-wide analysis high risk human disease improved insertion/deletion mutation polygenic risk score precision medicine rare variant risk prediction risk variant trait whole genome

项目摘要

Project Summary/Abstract Whole-genome sequencing of population biobank cohorts holds great promise for enabling accurate prediction of genetically-mediated risk for heritable human diseases and traits. Such information has the potential to be a powerful resource for precision medicine, informing preventative and therapeutic decisions. To more fully realize this potential, new statistical methods are needed to incorporate all genetic variants – including structural variants, blood-derived somatic mutations, and rare SNPs and indels – into genetic risk models. These classes of genetic variation, which are known to include many variants with large effects on disease risk, can be detected in high-coverage whole-genome sequencing data now being generated at biobank scale. However, such variants have not been accessible from previous genetic data sets (which have relied on SNP- array genotyping and imputation). Consequently, existing methods for polygenic prediction have typically considered only common inherited SNPs and indels. We propose to develop a suite of statistical methods to enable these additional classes of genetic variants to be incorporated into models of genetic risk, thereby improving predictive power. For variant types that are currently difficult to ascertain even from whole-genome sequencing data – including somatic mutations and some types of structural variants – we will develop new genotyping algorithms that improve statistical inference by harnessing information across large sequenced cohorts. We will efficiently integrate information across all variant types into genetic risk models using fast Bayesian regression methods. We will apply these approaches to train genetic risk models for common diseases using data from very large biobank sequencing projects. This project will have three specific aims. First, we will develop and apply methods for incorporating structural variants into polygenic scores. Many structural variants are known to confer substantial disease risk but are at imperfectly modeled by existing polygenic scores, such that directly including such variants will increase prediction accuracy and cross-ancestry transferability. Second, we will develop and apply methods for incorporating somatic mutations detectable in blood-derived DNA into genetic risk models. Such acquired mutations, often indicative of clonal expansions of blood cells, provide an orthogonal source of risk compared to the inherited variants considered by standard polygenic scores. Third, we will develop and apply efficient computational methods for training polygenic score models on biobank-scale sequencing data. These methods will allow model-fitting to be performed on individual-level genetic data, optimizing prediction accuracy. We anticipate that these efforts will significantly improve performance of genetic risk models trained on current and future population-scale whole-genome sequencing data sets.

项目总结/文摘